Literature DB >> 21115328

Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.

Liron Rabany1, Mark Weiser, Nomi Werbeloff, Yechiel Levkovitz.   

Abstract

OBJECTIVE: The Scale for the Assessment of Negative Symptoms (SANS) is the most widely used instrument for measuring negative symptoms in schizophrenia. The validity of its factor structure has not been established. Congruence of the SANS and its subscales to the negative subscale of the Positive and Negative Symptom Scale (PANSS-N) and the Calgary Depression Scale for Schizophrenia (CDSS) were never explored. The current study revised SANS's structure and examined its correlations with the PANSS and the CDSS.
METHOD: Two-hundred and forty patients with schizophrenia with predominantly negative symptoms were analyzed. A principal component analysis was conducted for SANS. Spearman's correlations were conducted for SANS and PANSS-N, and for SANS and CDSS.
RESULTS: Principal Component Analyses (PCA) of SANS revealed four factors, corresponding to the original SANS subscales with two exceptions: Item #13 (grooming and hygiene) loaded on the alogia factor rather than on its original affective flattening factor, and Item #4 (poor eye contact) did not load onto any factor. The total PANSS-N score showed a moderate correlation with the SANS and all of its subscales. The total CDSS score showed a low negative correlation with the total SANS score and with its avolition subscale.
CONCLUSIONS: Our results supported the validity of SANS's structure except for "poor eye contact" and "grooming end hygiene". The moderate correlation between SANS and PANSS-N suggests that although they are not identical, they measure similar constructs. The low negative correlation between SANS and CDSS suggests that they measure different constructs.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21115328     DOI: 10.1016/j.schres.2010.09.023

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Evidence of IQ-modulated association between ZNF804A gene polymorphism and cognitive function in schizophrenia patients.

Authors:  Min Chen; Zhansheng Xu; Jinguo Zhai; Xin Bao; Qiumei Zhang; Huang Gu; Qiuge Shen; Lina Cheng; Xiongying Chen; Keqin Wang; Xiaoxiang Deng; Feng Ji; Chuanxin Liu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2012-02-29       Impact factor: 7.853

2.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

3.  Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial.

Authors:  Leandro da Costa Lane Valiengo; Stephan Goerigk; Pedro Caldana Gordon; Frank Padberg; Mauricio Henriques Serpa; Stephanie Koebe; Leonardo Afonso Dos Santos; Roger Alberto Marcos Lovera; Juliana Barbosa de Carvalho; Martinus van de Bilt; Acioly L T Lacerda; Helio Elkis; Wagner Farid Gattaz; Andre R Brunoni
Journal:  JAMA Psychiatry       Date:  2020-02-01       Impact factor: 21.596

4.  Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia.

Authors:  Wolfram An der Heiden; Anne Leber; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-23       Impact factor: 5.270

5.  Converting positive and negative symptom scores between PANSS and SAPS/SANS.

Authors:  Theo G M van Erp; Adrian Preda; Dana Nguyen; Lawrence Faziola; Jessica Turner; Juan Bustillo; Aysenil Belger; Kelvin O Lim; Sarah McEwen; James Voyvodic; Daniel H Mathalon; Judith Ford; Steven G Potkin
Journal:  Schizophr Res       Date:  2013-12-11       Impact factor: 4.939

6.  Predictors of community functioning in schizophrenia and substance use disorder patients.

Authors:  Simon Zhornitsky; Ginette Aubin; Joelle Desfossés; Elie Rizkallah; Tania Pampoulova; Olivier Lipp; Jean-Pierre Chiasson; Emmanuel Stip; Stéphane Potvin
Journal:  Community Ment Health J       Date:  2012-07-31

7.  Assessment of trait and state aspects of depression in schizophrenia.

Authors:  Joshua Chiappelli; Katie L Nugent; Kavita Thangavelu; Katherine Searcy; L Elliot Hong
Journal:  Schizophr Bull       Date:  2013-05-17       Impact factor: 9.306

8.  A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.

Authors:  Adrian Preda; Dana D Nguyen; Juan R Bustillo; Aysenil Belger; Daniel S O'Leary; Sarah McEwen; Shichun Ling; Lawrence Faziola; Daniel H Mathalon; Judith M Ford; Steven G Potkin; Theo G M van Erp
Journal:  Schizophr Res       Date:  2018-06-20       Impact factor: 4.939

9.  Instruments measuring blunted affect in schizophrenia: a systematic review.

Authors:  Sanja Kilian; Laila Asmal; Anneke Goosen; Bonginkosi Chiliza; Lebogang Phahladira; Robin Emsley
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

10.  Depressive symptoms in first episode psychosis: a one-year follow-up study.

Authors:  Nasrettin Sönmez; Kristin Lie Romm; Ole A Andreasssen; Ingrid Melle; Jan Ivar Røssberg
Journal:  BMC Psychiatry       Date:  2013-04-05       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.